Creo Medical Group PLC Asset Resilience Ratio

Latest as of June 2024: -0.29%

Creo Medical Group PLC asset resilience ratio. Creo Medical Group PLC (CREO) has an Asset Resilience Ratio of -0.29% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CREO defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

GBX-200.00K

≈ $-24.33 USD Cash + Short-term Investments

Total Assets

GBX69.30 Million

≈ $8.43K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Creo Medical Group PLC (2020–2023)

Asset resilience ratio of Creo Medical Group PLC from 2020 to 2023. This chart shows how Creo Medical Group PLC's Asset Resilience Ratio has changed over time. Read CREO total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Creo Medical Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Creo Medical Group PLC total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX-200.00K	-0.29%
Total Liquid Assets	GBX-200.00K	-0.29%

Asset Resilience Insights

Limited Liquidity: Creo Medical Group PLC maintains only -0.29% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Creo Medical Group PLC Industry Peers by Asset Resilience Ratio

Compare Creo Medical Group PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Vitrolife AB ST:VITR	Medical Devices	7.27%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Shanghai Sanyou Medical Co Ltd SHG:688085	Medical Devices	7.69%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Nanjing Vishee Medical Technology Co Ltd SHG:688580	Medical Devices	10.74%
TAIDOC TECHNOLOGY CORP TW:4736	Medical Devices	23.03%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	3.90%

Creo Medical Group PLC Asset Resilience Ratio by Year (2020–2023)

Creo Medical Group PLC asset resilience ratio by year from 2020 to 2023. The table below shows the annual Asset Resilience Ratio data for Creo Medical Group PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	20.23%	GBX15.50 Million ≈ $1.89K	GBX76.60 Million ≈ $9.32K	+20.44pp
2022-12-31	-0.20%	GBX-153.00K ≈ $-18.62	GBX75.34 Million ≈ $9.17K	-0.08pp
2020-12-31	-0.12%	GBX-112.00K ≈ $-13.63	GBX92.46 Million ≈ $11.25K	--

pp = percentage points

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$628.03K

GBX5.16 Billion GBX

Market Cap Rank

#30937 Global

#878 in UK

Share Price

GBX10.63

Change (1 day)

-2.30%

52-Week Range

GBX9.65 - GBX17.75

All Time High

GBX243.00